Jonathan Biller
CFO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Financial Officer, Head of Corporate Affairs | $388,850 | $1,478,067 |
| 2021 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Financial Officer, Head of Corporate Affairs | $530,140 | $2,832,035 |
| 2020 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Financial Officer, Head of Corporate Affairs | $500,000 | $769,328 |
| 2019 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Financial Officer, Head of CorporateAffairs | $39,583 | $3,183,889 |
| 2018 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Legal Officer | — | — |
| 2017 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Financial Officer, Head of Legal andCorporate Affairs | — | — |
Executive changes
-
Resigned chief financial officer and head of corporate affairs at Agios Pharmaceuticals, Inc. (AGIO)2022-09-16
-
Resigned chief financial officer, head of corporate affairs and principal financial officer at Agios Pharmaceuticals, Inc. (AGIO)2022-09-16
Earnings-call appearances
-
Agios Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-04
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-05
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-02-24
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-03
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-07-29
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-04-29
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2021-01-11
Agios Pharmaceuticals, Inc. (AGIO)
-
Agios Pharmaceuticals, Inc. Q3 FY2020 Earnings Call2020-11-05
Agios Pharmaceuticals, Inc. (AGIO)